EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK‐ADRC cohort

Kate E Foley iD, Zachary Winder, Tiffany L Sudduth, Barbara J Martin, Peter T Nelson, Gregory A Jicha, Jordan P Harp, Erica M Weekman, Donna M Wilcock iD

Alzheimer's & Dementia · 2024-02 · 20 (2) · 1374-1386

DOI: 10.1002/alz.13485 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 27.11.2023. Verfasst von Kate E Foley und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Protein‐based plasma assays provide hope for improving accessibility and specificity of molecular diagnostics to diagnose dementia. METHODS Plasma was obtained from participants (N = 837) in our community‐based University of Kentucky Alzheimer's Disease Research Center cohort. We evaluated six Alzheimer's disease (AD)‐ and neurodegeneration‐related (Aβ40, Aβ42, Aβ42/40, p‐tau181, total tau, and NfLight) and five inflammatory biomarkers (TNF𝛼, IL6, IL8, IL10, and GFAP) using the SIMOA‐based protein assay platform. Statistics were performed to assess correlations. RESULTS Our large cohort reflects previous plasma biomarker findings. Relationships between biomarkers to understand AD–inflammatory biomarker correlations showed significant associations between AD and inflammatory biomarkers suggesting peripheral inflammatory interactions with increasing AD pathology. Biomarker associations parsed out by clinical diagnosis (normal, MCI, and dementia) reveal changes in strength of the correlations across the cognitive continuum. DISCUSSION Unique AD–inflammatory biomarker correlations in a community‐based cohort reveal a new avenue for utilizing plasma‐based biomarkers in the assessment of AD and related dementias. Highlights Large community cohorts studying sex, age, and APOE genotype effects on biomarkers are few. It is unknown how biomarker–biomarker associations vary through aging and dementia. Six AD (Aβ40, Aβ42, Aβ42/40, p‐tau181, total tau, and NfLight) and five inflammatory biomarkers (TNFα, IL6, IL8, IL10, and GFAP) were used to examine associations between biomarkers. Plasma biomarkers suggesting increasing cerebral AD pathology corresponded to increases in peripheral inflammatory markers, both pro‐inflammatory and anti‐inflammatory. Strength of correlations, between pairs of classic AD and inflammatory plasma biomarker, changes throughout cognitive progression to dementia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionHumansAmyloid beta-PeptidesInterleukin-10Interleukin-6Interleukin-8tau ProteinsBiomarkersUnited Kingdom

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid betabiomarkerinflammationplasma

Substanzen

Amyloid beta-PeptidesInterleukin-10Interleukin-6Interleukin-8tau ProteinsBiomarkers

Autor:innen und Institutionen

  • Sanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
  • Department of Physiology, University of Kentucky, Lexington, Kentucky, USA.
  • College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
  • Pathology and Laboratory Medicine, University of Kentucky, Lexington, Kentucky, USA.
  • Neurology, College of Public Health, University of Kentucky, Lexington, Kentucky, USA.

ORCID-Profile: Kate E Foley, Donna M Wilcock

Förderung

  • NIA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Foley, K. E., Winder, Z., Sudduth, T. L., Martin, B. J., Nelson, P. T., Jicha, G. A., Harp, J. P., Weekman, E. M., & Wilcock, D. M. (2024). Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK‐ADRC cohort. Alzheimer's & Dementia, 20(2), 1374-1386. https://doi.org/10.1002/alz.13485

Vancouver

Foley KE, Winder Z, Sudduth TL, Martin BJ, Nelson PT, Jicha GA, et al. Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK‐ADRC cohort. Alzheimer's & Dementia. 2024;20(2):1374-1386. doi:10.1002/alz.13485

BibTeX
@article{Foley2024,
  author = {Foley, Kate E and Winder, Zachary and Sudduth, Tiffany L and Martin, Barbara J and Nelson, Peter T and Jicha, Gregory A and Harp, Jordan P and Weekman, Erica M and Wilcock, Donna M},
  title = {Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK‐ADRC cohort},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {2},
  pages = {1374--1386},
  doi = {10.1002/alz.13485}
}
Kostenlos starten →